Hesperos Inc

Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the worlds most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the human body will...

In vitro biology,adme systems,nanotechnology,organ-on-a-chip,and organs-on-chips

Hesperos inc operates in the Biotechnology industry.

Hesperos inc's revenue is $55.50m

Hesperos inc has 51 - 200 employees.